Biosimilar Interchangeable Exclusivity Guidance Still Planned Despite Memo Release, US FDA Says

 
• By Derrick Gingery
  
compass
Many concepts in the memo could be reflected in upcoming guidance on biosimilar first interchangeable exclusivity. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Biosimilars & Generics